Principal Scientist, Oncology Research at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Highly motivated and creative scientist with extensive knowledge of T cell Engagers and related fields
Experience managing an internal research team and leading productive research teams
Ability to interact in a highly cross-functional manner across multiple departments
Expertise in identifying and validating novel targets for T cell Engagers
Expertise in developing next-generation approaches to make T cell engagers safer and more efficacious against solid tumors through engineering or novel combination approaches
Expertise in understanding the mechanism of action of T cell engagers and resistance mechanisms through innovative pre-clinical model development and analysis
Ability to supervise and guide multiple programs
Experience supporting external diligence efforts and evaluating assets as well as novel platforms
Passionate, ambitious, collaborative, determined, with a relentless drive to make a difference (as a people leader evolving culture for inclusion, development, and empowerment)

Responsibilities

Design and lead cross-functional therapeutic projects in the field of T cell engagers and enhancers of T cell functions, leveraging internal and external resources
Lead from the bench and actively participate in the design and execution of critical experiments
Support the development of Oncology portfolio at Gilead through project ideation and scientific experimentation
Manage reports and lead a productive research team dedicated to identifying and validating new targets for given cancer indications and developing new biologics platforms
Ideate and advance projects in a highly cross-functional manner across multiple departments
Supervise and guide multiple programs
Support external diligence efforts and evaluate assets as well as novel platforms

Skills

Oncology Research

Drug Discovery

Cancer Therapeutics

Biomedical Research

Scientific Innovation

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free